Devonian Health Group Inc. (TSXV:GSD)

Revenue by Segment

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018	Jul 31, 2017	Jul 31, 2016
Pharmaceutical	23.59M	19.31M	2.35M	2.31M	1.47M
Pharmaceutical Growth	22.19%	723.15%	1.74%	56.32%	-31.19%
Total	23.59M	19.31M	2.35M	2.31M	1.47M
Total Growth	22.19%	723.15%	1.74%	56.32%	-31.19%

Revenue by Geography

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018	Jul 31, 2017	Jul 31, 2016
Canada	23.59M	19.31M	2.35M	2.31M	1.47M
Canada Growth	22.19%	723.15%	1.74%	56.32%	-31.19%
Total	23.59M	19.31M	2.35M	2.31M	1.47M
Total Growth	22.19%	723.15%	1.74%	56.32%	-31.19%

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error